KEITH M BENBENISTY M.D. NPI 1265495782

NPI Details

Keith M Benbenisty, M.D. is a procedural dermatology dermatology in Fort Myers, FL with 26 years of experience. The provider is procedural Dermatology, a subspecialty of Dermatology, encompassing a wide variety of surgical procedures and methods to remove or modify skin tissue for health or cosmetic benefit. These methods include scalpel surgery, laser surgery, chemical surgery, cryosurgery (liquid nitrogen), electrosurgery, aspiration surgery, liposuction, injection of filler substances, and Mohs micrographic controlled surgery (a special technique for the removal of growths, especially skin cancers). Keith M Benbenisty, M.D. NPI is 1265495782. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Graduation Year:2000

The provider's business location address is:

8381 RIVERWALK PARK BLVD
SUITE 101
FORT MYERS, FL
ZIP 33919-760
Phone: (239) 936-5425
Fax: (239) 936-5176

The NPI 1265495782 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tildrakizumab, 1 mg (HCPCS:J3245)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:17271)
• Biopsy of ear (HCPCS:69100)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11301)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm (HCPCS:12052)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:17282)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:17280)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm (HCPCS:96921)
• Treatment of inflammatory skin disease using laser, less than 250.0 sq cm (HCPCS:96920)
• Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm (HCPCS:13132)
• Removal of skin tag, 1-15 skin tags (HCPCS:11200)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less (HCPCS:17260)
• Shaving of skin growth of body, arms, or legs, 0.5 cm or less (HCPCS:11300)
• Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11302)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:11310)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less (HCPCS:12051)
• Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11622)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:11306)
• Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm (HCPCS:12042)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11311)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less (HCPCS:11305)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less (HCPCS:17270)
• Application of light to destroy precancer skin growth (HCPCS:96567)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11641)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 4/7/2006 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.